Stockscreener 앱 받기
73.24
2.35%
-1.76
시간 외 거래:
73.23
-0.010
-0.01%
Alcon Inc 주식(ALC)의 최신 뉴스
Alcon’s potential manufacturing moves have Fort Worth eyeing tax breaks - Fort Worth Report
Alcon’s Stock Slide Offers Potential For Patient Investors - Finimize
What Makes Alcon (ALC) a Good Investment? - Yahoo
Major shareholder Yunqi Capital to vote against Staar Surgical 's proposed sale to Alcon - MSN
Alcon unveils $60M facility expansion in Cabell County - WOWK 13 News
Alcon investing $60 million in its West Virginia facility in Cabell County - WCHS
Alcon AG stock hits 52-week low at $74.83 By Investing.com - Investing.com UK
Broadwood opposes Alcon’s acquisition of STAAR Surgical - Investing.com India
Broadwood opposes Alcon’s acquisition of STAAR Surgical By Investing.com - Investing.com South Africa
STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates Fairness of Proposed STAAR Surgical Company (NASDAQ: STAA) Shareholder Buyout and Encourages Investors to Contact the Firm to Discuss their Legal Rights and Options - GlobeNewswire Inc.
Alcon Move to Acquire STAAR Surgical for $1.5 Billion Opposed by Broadwood Partners - MarketScreener
Broadwood Partners (27.5% Owner) Opposes STAAR's $28/Share Alcon Deal | STAA Stock News - Stock Titan
Alcon considers moving manufacturing lines to Fort Worth from Europe, creating hundreds of jobs - The Business Journals
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why - Stocktwits
STAAR confirms no competing bids emerged during Alcon merger window By Investing.com - Investing.com Nigeria
STAAR draws no rival bids as Yunqi joins Broadwood against Alcon deal - Investing.com Canada
Yunqi Capital opposes STAAR Surgical’s merger with Alcon By Investing.com - Investing.com South Africa
STAAR confirms no competing bids emerged during Alcon merger window - Investing.com India
Staar has no competing bids, another shareholder rejects Alcon buy - BioWorld MedTech
Yunqi Capital Announces its opposition to the STAAR Surgical? s proposed sale to Alcon - MarketScreener
Merger Agreement Advances as Alcon (ALC) Clears 'Window Shop' Pe - GuruFocus
Fort Worth weighs incentives for Alcon; Dallas mulls permit for outdoor concerts in Design District - The Business Journals
Yunqi Capital Opposes Staar Surgical (STAA) Sale to Alcon - GuruFocus
Yunqi Capital Rejects Alcon's Acquisition Proposal of STAAR Surg - GuruFocus
Yunqi Capital opposes STAAR Surgical’s merger with Alcon - Investing.com
Staar Surgical urges shareholders to back Alcon merger as “window shop” period ends (STAA:NASDAQ) - Seeking Alpha
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon - Bluefield Daily Telegraph
$28 vs Previous $55 Offer: Major STAAR Surgical Investor Yunqi Capital Fights Against 'Undervalued' Alcon Deal - Stock Titan
Refractive Surgery Market Booming Rapidly by 2032: Alcon Inc., Johnson & Johnson Vision, Bausch + Lomb - openPR.com
Trade Recap: Does Alcon Inc stock benefit from AI growthPortfolio Value Summary & Verified Short-Term Plans - خودرو بانک
VIX Spike: Is Alcon Incs growth already priced inDip Buying & Free Community Consensus Stock Picks - khodrobank.com
Pullback Watch: What is the next catalyst for PTMNTrade Risk Assessment & Weekly High Return Forecasts - khodrobank.com
Bond Watch: Will Alcon Inc benefit from rate cutsMarket Activity Summary & Reliable Price Breakout Signals - khodrobank.com
Fuchs endothelial corneal dystrophy Market Analysis: Epidemiology Insights, Therapies, Companies, by DelveInsight | Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon - Barchart.com
Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up - Nasdaq
Aug Retail: Should I hold or sell Tectonic Therapeutic Inc. nowIPO Watch & AI Enhanced Market Trend Forecasts - خودرو بانک
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
Alcon AG stock hits 52-week low at $77.34 amid challenging year By Investing.com - Investing.com South Africa
Alcon AG stock hits 52-week low at $77.34 amid challenging year - Investing.com Australia
Growth Value: What is Alcon Inc.’s book value per share2025 Year in Review & High Accuracy Investment Signals - خودرو بانک
Gains Report: What is Bakkt Holdings Inc Equity Warrants 5 year growth outlook2025 Top Gainers & Free High Accuracy Swing Entry Alerts - خودرو بانک
Staar Surgical issues letter to stockholders regarding Alcon merger - Yahoo Finance
Trading Action: Is Alcon Inc forming a breakout patternJuly 2025 Volume & Fast Moving Stock Watchlists - خودرو بانک
Alcon upgraded to neutral by Redburn, operational execution cited - MSN
Tools to monitor Alcon Inc. recovery probabilityInsider Selling & Daily Market Momentum Tracking - newser.com
STAAR Surgical Announces Merger with Alcon - TipRanks
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $100.73 - 富途牛牛
Fuchs Endothelial Corneal Dystrophy Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | ProQR Therapeutics, Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon Inc., Emmecell - Barchart.com
51% Premium: Medical Device Leader Alcon to Acquire STAAR Surgical in Premium Cash Deal Worth $28 Per Share - Stock Titan
Alcon (ALC) Boosts Surgical Efficiency with Unity Vitreoretinal Cataract System - GuruFocus
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS - Yahoo Finance
Risk Check: Whats the MACD signal for Alcon IncShare Buyback & Consistent Income Trade Ideas - خودرو بانک
2.51%
자본화:
|
볼륨(24시간):